Moonlake Immunotherapeutics (MLTX) Stock Price, Quote & News

Company Profile

MoonLake Immunotherapeutics, a clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases. It develops Sonelokimab, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody for the treatment of inflammatory diseases, as well as for hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, palmoplantar pustulosis, and psoriasis. The company was founded in 2021 and is headquartered in Zug, Switzerland.

Industry: Biotechnology

Sector: Healthcare

Phone: 41 415108022

Website: www.moonlaketx.com

Address:

Dorfstrasse 29, Zug, Switzerland

Bigbadjohn89 Dec. 24 at 11:46 PM

$MLTX Boom

1 · Reply

Mlb165 Dec. 24 at 11:27 PM

$MLTX too much drama, and so much hate in the threads this week. What happened?

1 · Reply

Jacksandknaves Dec. 24 at 10:53 PM

$BMEA $MLTX how much are you down here ?

1 · Reply

EllaMalaka Dec. 24 at 10:49 PM

$MLTX He’s basically saying that his mom should have swallowed him 😂🤷‍♂️

0 · Reply

EllaMalaka Dec. 24 at 10:47 PM

$MLTX look at this guys page 🤣 what a loser, get a life 🤡

1 · Reply

LouKojak Dec. 24 at 10:07 PM

$MLTX I'm close to 100% that the fda meeting contained good news (of some kind). It would be insane to present bad news to the indystry's #1 platform.

1 · Reply

LouKojak Dec. 24 at 10:04 PM

$MLTX this popped into my head re FDA Meeting and JP Morgan. From a question I asked on the topic: "a company's decision to cancel its J.P. Morgan Healthcare Conference speaking time after receiving bad news from a Type B FDA meeting is a strategic business decision and would depend on several factors, but cancellation is possible. There is no general rule that mandates cancellation; rather, the company must weigh the pros and cons of presenting negative information to a large investment community. Factors Influencing the Decision Impact of the News: The severity of the "bad news" is the primary factor. If the feedback essentially halts or significantly delays a major drug development program, the company's entire value proposition might be fundamentally altered, making the original presentation irrelevant or misleading."

1 · Reply

jpstyle83 Dec. 24 at 8:31 PM

$MLTX Merry Christmas everyone

0 · Reply

Jacksandknaves Dec. 24 at 8:06 PM

$BMEA $MLTX how much you down on this play ?

4 · Reply

Bigbadjohn89 Dec. 24 at 7:39 PM

$MLTX

0 · Reply

MOONLAKE DECEMBER 15th DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds MoonLake Immunotherapeutics Investors to Contact the Firm

Dec 11, 2025, 10:08 AM EST - 13 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 11, 2025, 8:54 AM EST - 13 days ago

DEADLINE NEXT WEEK: Berger Montague Advises MoonLake Immunotherapeutics (NASDAQ: MLTX) Investors to Contact the Firm Before December 15, 2025

Dec 8, 2025, 1:23 PM EST - 16 days ago

MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 8, 2025, 9:00 AM EST - 16 days ago

Stock Picks From Seeking Alpha's November 2025 New Analysts

ABEV CEG CEPU EAT GLXY GT KOF

Dec 5, 2025, 8:18 AM EST - 19 days ago

MoonLake Immunotherapeutics (MLTX) Investors are Encouraged to Act before the Upcoming December 15 Securities Fraud Deadline – Contact BFA Law if You Lost Money

Dec 5, 2025, 8:06 AM EST - 19 days ago

MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman

Dec 4, 2025, 3:01 PM EST - 20 days ago

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority

Dec 4, 2025, 9:00 AM EST - 20 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 15, 2025 in MoonLake Lawsuit - MLTX

Dec 3, 2025, 7:46 AM EST - 21 days ago

MLTX NEWS: MoonLake Immunotherapeutics Sued for Securities Fraud after Stock Plummets 90% -- Investors Notified to Contact BFA Law by December 15 Deadline

Dec 2, 2025, 5:29 PM EST - 22 days ago

Bragar Eagel & Squire, P.C. Urges Investors of Cepton, and MoonLake to Inquire About Their Rights Before Upcoming Deadlines

CPTN

Dec 1, 2025, 5:52 PM EST - 23 days ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Dec 1, 2025, 3:18 PM EST - 23 days ago

MLTX SHAREHOLDERS: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15

Dec 1, 2025, 12:26 PM EST - 23 days ago

Voya MidCap Opportunities Strategy Q3 2025 Portfolio Review

APP FIX KTOS TW VRSK

Nov 30, 2025, 7:45 AM EST - 24 days ago

MLTX LAWSUIT: BFA Law Reminds MoonLake Immunotherapeutics Investors the Company has been Sued for Securities Fraud and to Contact BFA Law by December 15 Deadline

Nov 28, 2025, 5:50 PM EST - 26 days ago

MoonLake Immunotherapeutics' (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate -- Hagens Berman

Nov 27, 2025, 2:15 PM EST - 27 days ago

MoonLake Immunotherapeutics' (MLTX) Reported Phase 3 Trial Data for Sole Drug Candidate, 90% Stock Crash Triggers Investor Suit -- Hagens Berman

Nov 24, 2025, 6:08 AM EST - 4 weeks ago

MOONLAKE NOTICE: MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations after Stock Drops 90%, Investors Urged to Contact BFA Law

Nov 18, 2025, 12:33 AM EST - 5 weeks ago

MoonLake: Ignore The Panic, Catch The Upside

Nov 14, 2025, 6:08 AM EST - 5 weeks ago

MOONLAKE INVESTORS: MoonLake Immunotherapeutics (MLTX) has been Sued for Securities Fraud, Investors are Urged to Contact BFA Law

Nov 10, 2025, 8:15 AM EST - 6 weeks ago

MOONLAKE IMMUNOTHERAPEUTICS (NASDAQ: MLTX) DEADLINE ALERT Bernstein Liebhard LLP Reminds MoonLake Immunotherapeutics Investors of Upcoming Deadline

Nov 10, 2025, 6:06 AM EST - 6 weeks ago

MLTX STOCK NOTICE: MoonLake Immunotherapeutics Investors with Losses may have been Misled by the Company and are Urged to Contact BFA Law by December 15 Deadline

Nov 5, 2025, 7:11 AM EST - 7 weeks ago

MoonLake Immunotherapeutics Announces Pricing of $75 Million Underwritten Offering

Nov 5, 2025, 7:00 AM EST - 7 weeks ago

MoonLake Immunotherapeutics Reports Third Quarter 2025 Financial Results and Announces New Data from Clinical Trials of its Nanobody® Sonelokimab

Nov 1, 2025, 7:08 AM EDT - 7 weeks ago

MLTX INVESTOR REMINDER: MoonLake Immunotherapeutics Investors may have been Affected by Fraud -- Contact BFA Law if You Suffered Losses

Oct 28, 2025, 9:51 AM EDT - 2 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics

Oct 14, 2025, 12:03 PM EDT - 2 months ago

MoonLake Immunotherapeutics (MLTX) Faces Investor Scrutiny After Reporting Disappointing Phase 3 Trial Data For Lead Drug Candidate -- Hagens Berman

Oct 10, 2025, 8:18 AM EDT - 2 months ago

MLTX SECURITIES NOTICE: MoonLake Immunotherapeutics Securities Fraud Investigation is Pending – Contact BFA Law if You Lost Money

Bigbadjohn89 Dec. 24 at 11:46 PM

$MLTX Boom

1 · Reply

Mlb165 Dec. 24 at 11:27 PM

$MLTX too much drama, and so much hate in the threads this week. What happened?

1 · Reply

Jacksandknaves Dec. 24 at 10:53 PM

$BMEA $MLTX how much are you down here ?

1 · Reply

EllaMalaka Dec. 24 at 10:49 PM

$MLTX He’s basically saying that his mom should have swallowed him 😂🤷‍♂️

0 · Reply

EllaMalaka Dec. 24 at 10:47 PM

$MLTX look at this guys page 🤣 what a loser, get a life 🤡

1 · Reply

LouKojak Dec. 24 at 10:07 PM

$MLTX I'm close to 100% that the fda meeting contained good news (of some kind). It would be insane to present bad news to the indystry's #1 platform.

1 · Reply

LouKojak Dec. 24 at 10:04 PM

1 · Reply

jpstyle83 Dec. 24 at 8:31 PM

$MLTX Merry Christmas everyone

0 · Reply

Jacksandknaves Dec. 24 at 8:06 PM

$BMEA $MLTX how much you down on this play ?

4 · Reply

Bigbadjohn89 Dec. 24 at 7:39 PM

$MLTX

0 · Reply

rrobers6 Dec. 24 at 6:28 PM

$MLTX Merry Christmas from the racing capital of the world.

2 · Reply

Bigbadjohn89 Dec. 24 at 5:37 PM

$MLTX I buy 1 share to track the SP when I buy options. I was very fortunate to start loading up at $6. I have been rolling them ever since. This is just the beginning. GLTA and Merry Christmas

0 · Reply

jayjaynyc Dec. 24 at 5:28 PM

$MLTX So the May 2025 calls are pretty active for higher premiums. Tested it out on the 40 dollar calls and got 81 dollars:

1 · Reply

sh3r1ock Dec. 24 at 5:18 PM

$MLTX 🔒 🔒 🔒

0 · Reply

Doomsayer1000 Dec. 24 at 5:09 PM

$MLTX soon the chart will be filled with red and major max pain.

2 · Reply

septrading Dec. 24 at 5:05 PM

$MLTX The large gap between the trading price and the $10.00 max pain suggests that the options market is not yet fully pricing in a premium buyout. Usually, if a deal is widely expected, the max pain will migrate upward toward the expected deal price as traders buy short-term OTM calls.

1 · Reply

perplex Dec. 24 at 5:02 PM

$MLTX Even with the last week red it is still on the upward trend line on daily chart. Have a look it’s easy to see.

0 · Reply

Creisi Dec. 24 at 4:55 PM

$MLTX $BMEA Before I check out today, I want to answer one last question I received lately. Why do I battle shorts on specific stocks like $BMEA & $MLTX ? Well, I came from clinical biopharma and funding is a 24 hour a day task. There are many really good medicines being developed and there are some which are not. The bad ones, in my opinion, are fair game for shorts. The good ones are not. I am determined to ensure companies with solid science developing much needed medicines acheive their goal of helping millions in need. Many companies in CB are started by folks determined to make people happier. They are the only thing advancing medicine for everyone. Without them there would be far more injury, disease & epidemics. Many folks would die. These companies are the life line of our most precious commodity. Our health. Nothing on this planet is more important. I wish everyone a healthy and warm Christmas Holiday & a prosperous and caring 2026! Merry Christmas Everyone!

8 · Reply

cranberry1 Dec. 24 at 4:48 PM

$MLTX 85$

0 · Reply

cranberry1 Dec. 24 at 4:47 PM

$MLTX

0 · Reply

MrGreenScreen Dec. 24 at 3:53 PM

$MLTX low volume today. Probably do less than half a Milli Vanilli

0 · Reply

ms0632 Dec. 24 at 3:51 PM

$MLTX $20 by 1/6/26. Good news soon to drop.

0 · Reply

Market Cap	882.53M
Revenue (ttm)	0.00
Net Income (ttm)	-118.94M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.25

Volume	536,400
Avg Vol	2,263,644
Day's Range	N/A - N/A
Shares Out	64.23M
Stochastic %K	34%
Beta	1.21
Analysts	Sell
Price Target	$14.61